A federal appeals court’s decision this week to uphold two drugmakers’ 340B contract pharmacy restrictions left unanswered questions about the [...] …
Category: Pharma Industry
Teva Pharmaceuticals recently added the 40th drug to the list of medications included in its contract pharmacy policy restrictions for [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal appeals court today decided that the 340B statute does not prohibit drugmakers from placing conditions on the distribution [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Shortly before adjourning, the Minnesota legislature cleared and sent to the governor legislation to bar 340B contract pharmacy access restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Novo Nordisk announced it is providing 340B covered entities 12-months-worth of refunds on four drug products including two of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Maryland Gov. Wes Moore (D) this morning is signing legislation to make Maryland the sixth state to prohibit drugmaker 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
CVS Health recently cited drug manufacturers’ contract pharmacy restrictions as one of the causes for a 19% year-over-year income decline [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge scheduled an April 2025 trial date for AstraZeneca’s lawsuit against Arkansas’ 340B contract pharmacy access law as [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...] …
